Why Outsource to a New Drug Development CRO?
For small drug-discovery firms, outsourcing Preformulation CRO is the only economically viable route. For companies producing large numbers of NCEs, insourcing becomes an option. However, outsourcing to a preclinical CRO has many compelling advantages associated with increased expertise and lower total costs:
Preformulation development studies were conducted to determine the physical and chemicalcharacteristics of the compound of interest be it a small organic molecule, peptide or protein. The data of these studies generated were a prerequisite to dosage form development and also the data required for submission of the Chemistry, Manufacturing and Control (CMC) section of the Investigational New Drug application (IND). Adept provides the following general Preformulation development studies.
If your drug-discovery team needs help determining Preformulation studies, Adept can help, either as part our Drug development suport for your program, or as stand-alone consulting. Contact us for details